Zheng M, Zhang R, Yang X, Wang F, Guo X, Li L
Mol Divers. 2025; .
PMID: 40009149
DOI: 10.1007/s11030-025-11142-5.
Feng L, Wang Q, Zang R, Zhang M
Cytotechnology. 2024; 76(6):709-720.
PMID: 39435427
PMC: 11490469.
DOI: 10.1007/s10616-024-00648-9.
Zaker A, Peyvandi A, Fazli M, Bazgir N, Vakili K, Fathi M
Indian J Otolaryngol Head Neck Surg. 2024; 76(5):4096-4101.
PMID: 39376360
PMC: 11455825.
DOI: 10.1007/s12070-024-04790-w.
Kumar M, Sekhon P, Singh R
Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3652-3655.
PMID: 39130312
PMC: 11306833.
DOI: 10.1007/s12070-024-04665-0.
Li Y, Lin C, Chu Y, Wei Z, Ding Q, Gu S
Genomics Proteomics Bioinformatics. 2024; 22(4).
PMID: 39107908
PMC: 11522873.
DOI: 10.1093/gpbjnl/qzae056.
Synchronous laryngeal cancer.
Ciolofan M, Anghelina F, Vlaescu A, Mitroi M, Capitanescu A, Ionita E
Rom J Morphol Embryol. 2024; 65(2):309-315.
PMID: 39020546
PMC: 11384040.
DOI: 10.47162/RJME.65.2.18.
Clinical significance of type IV vascularization of laryngeal lesions according to the Ni classification.
Stanikova L, Kantor P, Fedorova K, Zelenik K, Kominek P
Front Oncol. 2024; 14:1222827.
PMID: 38333687
PMC: 10851150.
DOI: 10.3389/fonc.2024.1222827.
Occupational Risk Factors for Laryngeal Cancer in Tunisia: A Case Control Study.
Gaddour A, Brahem A, Mosbah H, Sridi C, Saidane M, Belakhdher M
Med Lav. 2023; 114(6):e2023047.
PMID: 38060209
PMC: 10731567.
DOI: 10.23749/mdl.v114i6.14588.
Diagnosis of Carcinogenic Pathologies through Breath Biomarkers: Present and Future Trends.
Vassilenko V, Moura P, Raposo M
Biomedicines. 2023; 11(11).
PMID: 38002028
PMC: 10669878.
DOI: 10.3390/biomedicines11113029.
The Diagnostic and Predictive Value of F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Laryngeal Squamous Cell Carcinoma.
Al-Ibraheem A, Abdlkadir A, Shagera Q, Saraireh O, Al-Adhami D, Al-Rashdan R
Cancers (Basel). 2023; 15(22).
PMID: 38001720
PMC: 10670341.
DOI: 10.3390/cancers15225461.
NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA.
Li Z, Li D, Yang T, Yao C
Cancer Biol Ther. 2023; 24(1):2274143.
PMID: 37948132
PMC: 10898813.
DOI: 10.1080/15384047.2023.2274143.
Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6).
Zhang D, Tang D, Liu P, Tao L, Lu L
Hum Cell. 2023; 37(1):323-336.
PMID: 37759147
DOI: 10.1007/s13577-023-00984-6.
Superior loco-regional control after primary surgery compared to chemo-radiotherapy for advanced stage laryngeal cancer.
Shelan M, Anschuetz L, Schubert A, Bojaxhiu B, Aebersold D, Elicin O
Front Oncol. 2023; 13:1132486.
PMID: 37593093
PMC: 10431594.
DOI: 10.3389/fonc.2023.1132486.
Digit ratio (2D:4D), laryngeal cancer and vocal fold leukoplakia.
Pietruszewska W, Morawska J, Manning J, Sitek A, Antoszewski B, Kasielska-Trojan A
J Cancer Res Clin Oncol. 2023; 149(11):9349-9359.
PMID: 37211562
PMC: 10374665.
DOI: 10.1007/s00432-023-04850-8.
[Overview of thyroid gland involvement and its prognostic value on advanced laryngeal cancer].
Li J, Qiu K, Ren J, Chen F, Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023; 37(1):72-75.
PMID: 36597373
PMC: 10128351.
DOI: 10.13201/j.issn.2096-7993.2023.01.014.
CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR-31-5p/COL5A1 axis.
Gong H, Wu W, Fang C, He D
Laryngoscope Investig Otolaryngol. 2022; 7(6):1951-1962.
PMID: 36544920
PMC: 9764770.
DOI: 10.1002/lio2.966.
SNHG20 promotes the development of laryngeal squamous cell carcinoma via miR-342-3p/MTDH axis.
Xie Z, Xiang H, Li J, Zhang X, Li W, Tan G
Heliyon. 2022; 8(8):e10085.
PMID: 36033309
PMC: 9399968.
DOI: 10.1016/j.heliyon.2022.e10085.
Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
Zhou G, Zhang S, Jin M, Hu S
BMC Cancer. 2022; 22(1):667.
PMID: 35715770
PMC: 9206315.
DOI: 10.1186/s12885-022-09766-z.
CAPRIN1 Enhances Chemoresistance and Glycolysis in Laryngeal Squamous Cell Carcinoma via Regulation of ZIC5.
Zhang Y, Zhang H, Dong J, Zhao P, Hao F, Han H
J Oncol. 2022; 2022:6160539.
PMID: 35571493
PMC: 9098336.
DOI: 10.1155/2022/6160539.
Effect of treatment modality on the long-term survival of patients with early glottic squamous cancer: a retrospective cohort study based on the SEER database.
Wang W, Zheng H, Zhang L, Yu L
Ann Transl Med. 2022; 10(8):440.
PMID: 35571433
PMC: 9096410.
DOI: 10.21037/atm-21-5288.